Pharmaceutical Preparations · DE · CIK 1790340
Developing novel anti-cancer medicines to keep patients alive and help them thrive
Comparable business profile · signals at a glance
In the 90 days to Jan 16, 2026: 5 insiders bought $234K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 16, 2026 | Brakewood Harold EugeneChief Business Officer | Buy | 5,250 | $4.76 | $25K |
| Jan 15, 2026 | Schall Thomas J.Director | Buy | 21,645 | $4.67 | $101K |
| Jan 15, 2026 | Hall Brett MatthewCHIEF SCIENTIFIC OFFICER | Buy | 2,298 | $4.57 | $11K |
| Jan 13, 2026 | Neufeld Leah RCHIEF PEOPLE OFFICER | Buy | 2,626 | $4.15 | $11K |
| Jan 12, 2026 | Feinberg PeterDirector | Buy | 20,000 | $4.35 | $87K |
| Oct 3, 2025 | Feinberg PeterDirector | Buy | 7,500 | $6.67 | $50K |
| Oct 1, 2025 | Bookman MichaelCHIEF LEGAL OFFICER, SECRETARY | Buy | 1,020 | $6.83 | $7K |
| Oct 1, 2025 | Neufeld Leah RCHIEF PEOPLE OFFICER | Buy | 800 | $6.38 | $5K |
| Oct 1, 2025 | Morales MalloryChief Accounting Officer | Buy | 300 | $6.39 | $2K |
| Sep 30, 2025 | Feinberg PeterDirector | Buy | 7,500 | $7.03 | $53K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.